 StemCyte, Inc. is a leading, global umbilical cord blood ("UCB") stem cell transplantation and therapeutic products company. StemCyte, headquartered in Southern California has UCB storage facilities in both California and Taiwan which collect, process and store UCB stem cells to be used as therapeutic treatments. Stem cells are used to replace or initiate the production of other cells that are damaged or missing due to disease. Unlike embryonic stem cells, which have been the subject of much public controversy, UCB stem cells are harvested from umbilical cords that would otherwise be discarded at the time of childbirth. UCB stem cells are already in clinical use and have been used in over 10,000 transplants worldwide. With an inventory of over 25,000 units, the Company's stem cell bank represents one of the largest and most ethnically diverse sources of high quality unrelated stem cell transplantation products derived exclusively from umbilical cord blood. StemCyte's products are currently being used to treat several patients per week worldwide who suffer from a variety of blood cancers and immune and genetic disorders.
Mission Statement
StemCyte is dedicated to helping the world's physicians save more lives by providing high quality, safe and effective stem cell transplantation and therapy to all patients in need.
|
